As part of the response to the migration flow from Venezuela, the Colombian Government is seeking to facilitate the work of a group of public and private players to give an effective and opportune response to Venezuelan migrants, Colombian returnees and host communities. In support to these efforts, the Colombian Red Cross has signed a cooperation agreement with Novartis, through which Venezuelan immigrants without health coverage or healthcare will have access to a portfolio of medicines for the treatment of chronic, non-transmissible diseases.
Tuesday, 4 December 2018 - 9:14pm
The 15 medicines included in the Novartis Access portfolio appear on the World Health Organization's model list of essential medicines (for cardiovascular and respiratory diseases; breast cancer and diabetes), and will be delivered to the Red Cross at a cost of 1 dollar per treatment per month, plus importation costs. The treatments will be free of charge for patients, and will be available as of the first quarter of 2019. The distribution of these medicines to the patients who require them will be done in the care units that the Red Cross has set up in various cities across the country.
The National Government welcomes this initiative and invites others in the private sector, NGOs and other organizations to promote efforts to continue responding to the current situation with a sense of responsibility and solidarity.
About the Red Cross
The Colombian Red Cross, present since 1915, has carried out its humanitarian work during periods of conflict, responding to the growing needs of displaced persons fleeing violence or who face dangerous situations. Its mission is to save lives and prevent and alleviate human suffering under all circumstances by strengthening community capacities, promoting a culture of peace, social inclusion, health, disaster risk management, adaptation to climate change, education, human rights and international humanitarian law.